We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

1 hedge funds and large institutions have $34.3M invested in Ariad Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 191 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% less funds holding in top 10

Funds holding in top 10: 9 → 1 (-8)

98% less capital invested

Capital invested by funds: $2.13B → $34.3M (-$2.09B)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 191

100% less funds holding

Funds holding: 200 → 1 (-199)

Holders
1
Holders Change
-199
Holders Change %
-99.5%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-88.89%
% of All Funds
0.02%
New
1
Increased
–
Reduced
–
Closed
191
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$16.5M

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$32M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$225M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$218M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$182M
4
SCM
Sarissa Capital Management
Connecticut
-$160M
5
State Street
State Street
Massachusetts
-$97.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
151
Paloma Partners
Connecticut
– -$187K -15,000 Closed
RJFSA
152
Raymond James Financial Services Advisors
Florida
– -$180K -14,500 Closed
Teacher Retirement System of Texas
153
Teacher Retirement System of Texas
Texas
– -$176K -14,129 Closed
FRM
154
Fox Run Management
Connecticut
– -$165K -13,300 Closed
Squarepoint
155
Squarepoint
New York
– -$165K -13,233 Closed
CG
156
Cutler Group
California
– -$159K -12,844 Closed
BNP Paribas Financial Markets
157
BNP Paribas Financial Markets
France
– -$159K -12,802 Closed
Fiera Capital (Canada)
158
Fiera Capital (Canada)
Quebec, Canada
– -$149K -11,946 Closed
QSS
159
Quantitative Systematic Strategies
Florida
– -$139K -11,192 Closed
Susquehanna International Group
160
Susquehanna International Group
Pennsylvania
– -$139K -11,138 Closed
N
161
Nuveen
North Carolina
– -$138K -11,075 Closed
FDCC
162
Foster Dykema Cabot & Co
Massachusetts
– -$126K -10,100 Closed
Zurich Cantonal Bank
163
Zurich Cantonal Bank
Switzerland
– -$103K -8,311 Closed
SO
164
STRS Ohio
Ohio
– -$102K -8,200 Closed
SEC
165
Seven Eight Capital
New York
– -$72K -5,800 Closed
US Bancorp
166
US Bancorp
Minnesota
– -$71K -5,687 Closed
SM
167
SG3 Management
Puerto Rico
– -$68K -5,500 Closed
AG
168
Advisor Group
Arizona
– -$52K -4,203 Closed
CSS
169
Cubist Systematic Strategies
Connecticut
– -$51K -4,100 Closed
Bank of Montreal
170
Bank of Montreal
Ontario, Canada
– -$47K -3,460 Closed
AIM
171
Acrospire Investment Management
Illinois
– -$34K -2,750 Closed
IA
172
IFP Advisors
Florida
– -$31K -2,500 Closed
Nisa Investment Advisors
173
Nisa Investment Advisors
Missouri
– -$25K -2,000 Closed
PG
174
Patten Group
Tennessee
– -$47K -2,000 Closed
FPFS
175
First Personal Financial Services
North Carolina
– -$24K -1,966 Closed
4 5 6
7
8

ARIA Hedge Fund Activity: Q1 2017 in Review

1 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2017, worth a combined $34.3M — down 98% from $2.13B a quarter earlier.

Sellers outnumbered buyers: 191 funds closed out of ARIA and 1 opened new positions — a net loss of 190 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $32M. The largest seller was Fidelity Investments, exiting entirely with an estimated $225M sold.

  • 1 institutional investor held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2017, down from 200 in Q4 2016.
  • Funds reported $34.3M of Ariad Pharmaceuticals Inc stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Ariad Pharmaceuticals Inc positions in Q1 2017 and 191 closed out, a net change of -190 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2017 was FNY Partners Fund, an estimated $32M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2017 was Fidelity Investments, an estimated $225M sold.

Based on aggregated 13F filings for Q1 2017.